Cita APA

Tengström, M., Mannermaa, A., Kosma, V., Hirvonen, A., & Kataja, V. (2012). SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer? BioMed Central.

Citación estilo Chicago

Tengström, Maria, Arto Mannermaa, Veli-Matti Kosma, Ari Hirvonen, y Vesa Kataja. SULT1A1 Rs9282861 Polymorphism-a Potential Modifier of Efficacy of the Systemic Adjuvant Therapy in Breast Cancer? BioMed Central, 2012.

Cita MLA

Tengström, Maria, et al. SULT1A1 Rs9282861 Polymorphism-a Potential Modifier of Efficacy of the Systemic Adjuvant Therapy in Breast Cancer? BioMed Central, 2012.